The National Breast Cancer Foundation (NBCF) has partnered with the Cure Brain Cancer Foundation in a bid to connect the dots between breast and brain cancer.
The aim is to tackle the most critical clinical questions affecting women diagnosed with breast and/or brain cancer.
A NBCF-funded study by Associate Professor Pilar Blancafort will investigate a new gene editing technology for brain cancer and metastatic breast cancer that will look at new treatments for highly resistant types of cancers.
The project will target genes which allow the cancer cells to repair themselves during radiotherapy and chemotherapy, leading to treatment resistance.
Associate Professor Blancafort will address difficult-to-treat cancers “by specifically targeting the subtypes of cancer with the worst prognosis for which there are no cures or targeted approaches available, with innovative treatments that are selective for these patients.”
Her research is vital for NBCF’s target of achieving zero deaths from breast cancer by 2030.
Read more about her project here.